Cubist Systematic Strategies’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$1.94M Sell
17,500
-23,600
-57% -$2.68M 0.01% 1585
2025
Q2
$4.56M Sell
41,100
-13,400
-25% -$1.43M 0.02% 1069
2025
Q1
$6.11M Buy
54,500
+18,400
+51% +$1.9M 0.04% 764
2024
Q4
$3.33M Buy
36,100
+29,000
+408% +$2.61M 0.02% 1059
2024
Q3
$595K Sell
7,100
-17,800
-71% -$1.36M ﹤0.01% 2132
2024
Q2
$1.71M Sell
24,900
-29,300
-54% -$1.96M 0.01% 1433
2024
Q1
$3.97M Sell
54,200
-4,100
-7% -$315K 0.02% 1118
2023
Q4
$4.72M Sell
58,300
-22,900
-28% -$1.78M 0.03% 902
2023
Q3
$6.09M Sell
81,200
-84,900
-51% -$6.53M 0.04% 636
2023
Q2
$12.8M Sell
166,100
-133,700
-45% -$10.7M 0.09% 309
2023
Q1
$24.9M Sell
299,800
-93,100
-24% -$7.71M 0.15% 101
2022
Q4
$33.7M Buy
392,900
+357,000
+994% +$28.3M 0.2% 37
2022
Q3
$2.21M Sell
35,900
-22,100
-38% -$1.39M 0.01% 1901
2022
Q2
$3.58M Buy
+58,000
New +$3.59M 0.02% 1301

Other funds holding GILD

Cubist Systematic Strategies's GILD Position: Q3 2025 in Review

Cubist Systematic Strategies sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 50,395 shares — an estimated $5.73M sold.

Cubist Systematic Strategies first reported a position in GILD in Q2 2014 and held it in 43 quarters. The position peaked at $41.4M in Q4 2022. 2,027 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Cubist Systematic Strategies reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 50,395 Gilead Sciences shares in Q3 2025, an estimated $5.73M.
  • Cubist Systematic Strategies first reported a position in Gilead Sciences in Q2 2014 and held it in 43 quarters.
  • Cubist Systematic Strategies's Gilead Sciences position peaked at $41.4M in Q4 2022.
  • 2,027 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.